Open AccessSecukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS)-Related Remission: 2-Year Results from a Phase 3 Study
Author(s) -
Laura C. Coates,
Gladman Dd,
Peter Nash,
Oliver FitzGerald,
Arthur Kavanaugh,
Lawrence Rasouliyan,
Luminita Pricop,
Kevin Ding,
Corine Gaillez
Publication year - 2018
Publication title -
skin the journal of cutaneous medicine
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.17
Subject(s) - secukinumab , psoriatic arthritis , medicine , phase (matter) , arthritis , dermatology , chemistry , organic chemistry
not available. Disclosures: Study sponsored by Novartis. Copyright 2018 SKIN
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom